Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 26, 2026
Global X Copper Miners ETF (COPX): Tracking Copper Volatility and Structural Demand

Global X Copper Miners ETF (COPX): Tracking Copper Volatility and Structural Demand

Key Takeaways

  • COPX tracks the Solactive Global Copper Miners Index, offering diversified exposure to roughly 40 global copper mining, exploration, and refining companies.
  • Largest holdings include FCX (Freeport-McMoRan), Antofagasta, Zijin Mining, Lundin Mining, and Ivanhoe Mines, with roughly 95% of assets concentrated in the materials sector.
  • Over the past 30 days the fund pulled back about 9%, while it remains up roughly 13% over the past quarter, reflecting elevated but uneven copper-market volatility.
  • Structural demand drivers include electrification, renewable-energy build-out, grid modernization, and energy-intensive data-center and AI infrastructure.
  • Principal risks center on copper-price swings, China demand, supply disruptions, and sensitivity to interest rates and global growth.

COPX ETF Overview and Holdings

The Global X Copper Miners ETF (COPX) is a passively managed exchange-traded fund that seeks to track the price and yield performance of the Solactive Global Copper Miners Index. The index focuses on companies globally that derive meaningful revenue from copper mining, exploration, and refining. It holds roughly 40 constituents, with individual positions capped near the 5% mark to limit concentration.

The fund carries an expense ratio of 0.65%, and its assets under management exceed $7 billion. Geographic exposure leans heavily toward Canada at roughly 35%–37%, followed by allocations to the United States, Australia, and China. Top holdings feature FCX (Freeport-McMoRan), Antofagasta, Zijin Mining, Lundin Mining, Ivanhoe Mines, TECK (Teck Resources), SCCO (Southern Copper), and HBM (Hudbay Minerals), along with BHP, Glencore, and KGHM Polska Miedz. Because the portfolio tilts toward pure-play producers, COPX functions as a high-beta proxy for copper prices. I also checked this using Tickeron’s AI Screener to compare the fund’s holdings against peers in the sector.

Industry Themes and Long-Term Drivers

Copper occupies a central role in several enduring investment themes. The metal supports electrification, power transmission, electric vehicles, renewable-energy generation, and the power demands of data-center expansion linked to artificial intelligence. These structural factors support a constructive long-term view for copper miners, even while near-term prices respond to cyclical pressures.

Supply remains constrained by declining ore grades, extended permitting timelines, and occasional disruptions in key regions such as Chile and Peru. This backdrop of steady demand and tighter supply has sustained elevated copper prices and strong cash-flow generation for producers. Macro conditions still matter: the sector remains sensitive to global industrial activity, monetary policy, and China’s economic path as the largest consumer of the metal.

Recent Performance and Market Positioning

COPX has followed a volatile yet upward path in recent months. Over the past quarter the fund advanced roughly 13%, extending gains as copper prices stayed elevated and miner margins remained wide. In the most recent 30-day period, however, the fund declined about 9%, mirroring a pullback in copper prices and some profit-taking after the prior advance.

The recent softness stems from several influences. Copper-price declines affect a fund whose largest positions are leveraged to the metal. Holdings such as Freeport-McMoRan, Antofagasta, Zijin Mining, and Southern Copper tend to move in line with copper, magnifying both gains and losses. Broader sentiment around global growth, China’s property and manufacturing sectors, and interest-rate expectations has added to short-term swings. The pattern reflects the behavior of a commodity-linked equity ETF more than a low-volatility diversified product. From what I see, this volatility is typical for the space, and I’m watching how it interacts with broader market moves.

2026 Outlook and Factors to Watch

Several structural elements are likely to influence COPX through the rest of 2026. On the demand side, the pace of electrification, renewable-energy projects, grid investment, and data-center construction will shape copper use, while China’s stimulus and industrial activity will guide near-term consumption. On the supply side, mine output, labor talks in Chile and Peru, and new project approvals will affect the market balance.

Macro conditions remain relevant. Interest-rate expectations and the U.S. dollar path influence commodity prices and cyclical equity valuations, while inflation trends affect miner costs such as energy and labor. Earnings trends among major holdings, capital-allocation choices, and M&A activity in the copper sector may also drive results. Regulatory developments and competition from other thematic copper products could influence flows. The long-term structural case for copper stays intact, yet investors should prepare for ongoing volatility given the fund’s concentrated profile.

Using Tickeron Tools for Sector Analysis

In my own research process I frequently rely on Tickeron’s AI tools to scan for related opportunities and confirm thematic exposure. The platform’s combination of technical signals, fundamentals, and customizable filters helps surface ideas within the copper-mining space more efficiently than manual review alone. For investors looking to complement ETF analysis with single-stock or sector insights, the AI Screener offers a practical way to explore these themes in greater depth.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: COPX

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


COPX sees MACD Histogram just turned negative

COPX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 01, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In 40 of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for COPX moved out of overbought territory on August 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 38 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 86%.

The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on COPX as a result. In 78 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COPX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

COPX broke above its upper Bollinger Band on August 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 52 of 55 cases where COPX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

COPX moved above its 50-day moving average on September 17, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +3.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where COPX advanced for three days, in 294 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

The Aroon Indicator entered an Uptrend today. In 274 of 296 cases where COPX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Notable companies

The most notable companies in this group are BHP Group Limited (NYSE:BHP), Freeport-McMoran (NYSE:FCX).

Industry description

The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Global Copper Miners Total Return Index. The fund invests at least 80% of its total assets in the securities of the underlying index and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the underlying index. The underlying index is designed to measure broad-based equity market performance of global companies involved in the copper mining industry. The fund is non-diversified.

Market Cap

The average market capitalization across the Global X Copper Miners ETF (COPX) ETF is 59.07B. The market cap for tickers in the group ranges from 11.82B to 216.17B. BHP holds the highest valuation in this group at 216.17B. The lowest valued company is HBM at 11.82B.

High and low price notable news

The average weekly price growth across all stocks in the Global X Copper Miners ETF (COPX) ETF was -1%. For the same ETF, the average monthly price growth was -9%, and the average quarterly price growth was 22%. BHP experienced the highest price growth at -2%, while BHP experienced the biggest fall at -2%.

Volume

The average weekly volume growth across all stocks in the Global X Copper Miners ETF (COPX) ETF was -55%. For the same stocks of the ETF, the average monthly volume growth was 18% and the average quarterly volume growth was -60%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 69
Price Growth Rating: 53
SMR Rating: 93
Profit Risk Rating: 75
Seasonality Score: 25 (-100 ... +100)
View a ticker or compare two or three
COPX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category NaturalResources

Category
Natural Resources
Address
Global X Funds600 Lexington Avenue, 20th FloorNew York
Phone
+1 8884938631
Web
www.globalxfunds.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.